Stock sales from drug developers are off to a flying start on US exchanges in 2026, boosting the prospects for biotechnology ...

A successful Phase 3 trial and a public offeringof stock boosted prospects for this company to receive approval for an ...

Explore India's potential in futuristic marine and space biotechnology to enhance biomanufacturing and strengthen its ...

南京林业大学 林草学院、水土保持学院珍贵树种研究团队在《Plant Biotechnology Journal》上在线发表了题为“Two Indel Variations in the Regulated Carotenoid Pigment ...

The opening session sets the context and intent for the Inaugural Summit: USA-Saudi Biotech Alliance, outlining the strategic ...

An inconsistent boom-and-bust cycle funding environment for early-stage biotech innovations and burdensome regulation ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine, as global R&D investment approaches $360 billion ...

Sulfolobus islandicus, an archaeal model organism, offers unique advantages for metabolic engineering and synthetic biology ...

Sana Biotechnology, Inc. surged after hedge fund manager Eric Jackson called it a potential "100-bagger" due to its pioneering diabetes cell therapy. Sana Biotechnology's breakthrough islet cell ...

Triple-leveraged ETFs aren’t for everyone, but if you believe biotech is about to break out, Direxion Daily S&P Biotech Bull ...

Can gene editing truly support smallholder farmers and help Indonesia achieve food sovereignty, or will it simply revive the ...

The average one-year price target for MAIA Biotechnology (NYSEAM:MAIA) has been revised to $10.48 / share. This is a decrease ...